Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin

被引:4
|
作者
Akatsu Y. [1 ]
Saikawa Y. [1 ]
Kubota T. [1 ]
Yoshida M. [1 ]
Furukawa T. [1 ]
Otani Y. [1 ]
Kumai K. [2 ]
Kitajima M. [1 ]
机构
[1] Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582
[2] Ctr. for Diagn./Therapeut. Endoscopy, Keio University School of Medicine, Tokyo
关键词
Cisplatin; Gastric cancer; Peritoneal dissemination; S-1;
D O I
10.1007/s10120-004-0281-8
中图分类号
学科分类号
摘要
A 54-year-old woman with severe abdominal distention suffered from massive ascites. Cytological examination revealed adenocareinoma cells, leading to a diagnosis of peritonitis carcinomatosa. Gastrointestinal fiberseopy (GIF) resulted in a histological diagnosis of type 4 advanced gastric cancer with signet-ring cell carcinoma. The clinical diagnosis was confirmed to be cT3(SE)cN1cM0cH0cP1, cStage IV gastric cancer, type 4, according to the Japanese classification of gastric carcinoma. The patient was treated with S-1 and low-dose cisplatin (CDDP) in order to alleviate the critical state of the disease. After the third cycle of the regimen, the clinical response of P1 was classified as a partial response (PR) according to the World Health Organization (WHO) criteria. The patient's appetite loss and abdominal discomfort were markedly alleviated. The patient experienced grade 2 leukocytopenia throughout the regimen. Surgery was performed. Ascites and peritoneal disseminated lesions were not observed, and cytological examination of the peritoneal washes was negative. Total gastrectomy with D1 lymph node dissection was performed, and the surgical diagnosis was sT3(SE)sN0sM0sH0sP0; sStage II Microscopically, viable cancer cells were found to be scattered throughout the subserosal-serosal layers in the resected stomach. All of the samples from lesions that were potentially cancers involving peritoneal dissemination were diagnosed as fibrous scar tissues without any viable cancer cells. The patient is alive without recurrence at 10 months after surgery and 14 months after the initial chemotherapy. Thus, systemic chemotherapy with S-1/low-dose CDDP achieved desirable control of peritoneal disseminated cells, as assessed microscopically, suggesting that the regimen may be an effective strategy for the treatment of advanced gastric cancer with peritonitis carcinomatosa.
引用
收藏
页码:128 / 133
页数:5
相关论文
共 50 条
  • [41] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    John Spiliotis
    Odysseas Zoras
    World Journal of Surgery, 2011, 35 : 468 - 469
  • [42] Staging laparoscopy and neoadjuvant chemotherapy of biweekly docetaxel and S-1 for gastric cancer with peritoneal dissemination.
    Kakeji, Y.
    Oki, E.
    Yoshinaga, K.
    Saeki, H.
    Tokunaga, E.
    Morita, M.
    Kitao, H.
    Emi, Y.
    Sakaguchi, Y.
    Maehara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    Ito, Seiji
    WORLD JOURNAL OF SURGERY, 2011, 35 (02) : 470 - 471
  • [44] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Sasaki, Kinro
    Onodera, Shinichi
    Otsuka, Kichiro
    Satomura, Hitoshi
    Kurayama, Eigo
    Kubo, Tsukasa
    Takahashi, Masakazu
    Ito, Jun
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Miyachi, Kazuhito
    Kato, Hiroyuki
    MEDICAL ONCOLOGY, 2017, 34 (08)
  • [45] Feasibility Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 for Advanced Gastric Cancer
    Fujitani, Kazumasa
    Hasegawa, Hiroko
    Hirao, Motohiro
    Kurokawa, Yukinori
    Tsujinaka, Toshimasa
    ANTICANCER RESEARCH, 2011, 31 (09) : 3085 - 3091
  • [46] Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer
    Migita, Kazuhiro
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Matsuki, Atsushi
    Aizawa, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 102 - 109
  • [47] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Kinro Sasaki
    Shinichi Onodera
    Kichiro Otsuka
    Hitoshi Satomura
    Eigo Kurayama
    Tsukasa Kubo
    Masakazu Takahashi
    Jun Ito
    Masanobu Nakajima
    Satoru Yamaguchi
    Kazuhito Miyachi
    Hiroyuki Kato
    Medical Oncology, 2017, 34
  • [48] Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer
    Kazuhiro Migita
    Atsushi Nashimoto
    Hiroshi Yabusaki
    Atsushi Matsuki
    Masaki Aizawa
    International Journal of Clinical Oncology, 2016, 21 : 102 - 109
  • [49] NEOADJUVANT CHEMOTHERAPY WITH A COMBINATION OF S-1 AND CISPLATIN IN NONRESECTABLE ADVANCED GASTRIC CANCER: A SHORT COMMUNICATION
    Kosaka, T.
    Hosokawa, K.
    Yokoi, M.
    Kinami, S.
    Omote, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 117 - 117
  • [50] Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report
    Muto, Jun
    Kishimoto, Hiroshi
    Kaizuka, Yasuo
    Kinjo, Mitsuru
    Higashi, Hidefumi
    Kishihara, Fumiaki
    IN VIVO, 2017, 31 (03): : 439 - 441